A House committee is looking into the FDA’s warning letter publication process; Amgen and Roche collaborate on cancer combination drug; study shows online health information fails teenagers
OPDP finds fault with Rapaflo website
May 21, 2015
6:30 pm
The FDA’s advertising division said images and copy for the BPH drug Rapaflo are misleading.
Banner triggers OPDP letter to Oak Pharmaceuticals
May 20, 2015
6:00 pm
The FDA’s bad-ad group said the banner they saw at a professional conference was misleading.
FDA takes aim at Abilify marketing material
April 29, 2015
5:00 pm
The regulator’s marketing watchdog said a sales tool makes promises that the drug’s label cannot support.